SCHEMBL604858

SCHEMBL604858

OC(c1cccc2ccccc12)(c1cccc2ccccc12)[C@@H]1CCCN1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.56
KDM4E B2RXH2 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
NPC1 O15118 1/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
RAB9A P51151 1/20 0.56
SSTR4 P31391 2/20 0.35
ADORA2A P29274 5/20 0.34
ADORA1 P30542 5/20 0.34
KCNH2 Q12809 4/20 0.34
CYP3A4 P08684 3/20 0.34
ADORA3 P0DMS8 2/20 0.34
ADORA2B P29275 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22259907 0.85 CYP2D6 (0.50) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL20833508 0.85 CYP2D6 (0.50) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL14326145 0.78 CYP2D6 (0.39) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL6441061 0.78 CYP2D6 (0.59) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326303 0.78 CYP2D6 (0.59) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10327031 0.78 CYP2D6 (0.59) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326923 0.76 CYP2D6 (0.60) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL10326637 0.76 CYP2D6 (0.60) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL6441272 0.76 CYP2D6 (0.60) CYP2D6KDM4ECYP1A2CYP2C19NPC1
SCHEMBL5527635 0.75 CYP2D6 (0.40) CYP2D6KDM4ECYP1A2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US disclosed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP disclosed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO disclosed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF ACKR3, KIT, C3AR1 CYP2D6 401/4885KDM4E 2343/4885CYP1A2 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.